These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 7896984)
1. Self-efficacy and illicit opioid use in a 180-day methadone detoxification treatment. Reilly PM; Sees KL; Shopshire MS; Hall SM; Delucchi KL; Tusel DJ; Banys P; Clark HW; Piotrowski NA J Consult Clin Psychol; 1995 Feb; 63(1):158-62. PubMed ID: 7896984 [TBL] [Abstract][Full Text] [Related]
2. A randomized clinical trial of the Recovery Line among methadone treatment patients with ongoing illicit drug use. Moore BA; Buono FD; Lloyd DP; Printz DMB; Fiellin DA; Barry DT J Subst Abuse Treat; 2019 Feb; 97():68-74. PubMed ID: 30577901 [TBL] [Abstract][Full Text] [Related]
3. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program. Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117 [TBL] [Abstract][Full Text] [Related]
4. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. Sees KL; Delucchi KL; Masson C; Rosen A; Clark HW; Robillard H; Banys P; Hall SM JAMA; 2000 Mar; 283(10):1303-10. PubMed ID: 10714729 [TBL] [Abstract][Full Text] [Related]
5. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone. Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786 [TBL] [Abstract][Full Text] [Related]
6. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification. Masson CL; Barnett PG; Sees KL; Delucchi KL; Rosen A; Wong W; Hall SM Addiction; 2004 Jun; 99(6):718-26. PubMed ID: 15139870 [TBL] [Abstract][Full Text] [Related]
7. Tailoring a brief intervention for illicit drug use and alcohol use in Irish methadone maintained opiate dependent patients: a qualitative process. Darker C; Sweeney B; Keenan E; Whiston L; Anderson R; Barry J BMC Psychiatry; 2016 Nov; 16(1):373. PubMed ID: 27809831 [TBL] [Abstract][Full Text] [Related]
8. A controlled trial of buprenorphine treatment for opioid dependence. Johnson RE; Jaffe JH; Fudala PJ JAMA; 1992 May; 267(20):2750-5. PubMed ID: 1578593 [TBL] [Abstract][Full Text] [Related]
9. Controlled trial of prescribed heroin in the treatment of opioid addiction. March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F; J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749 [TBL] [Abstract][Full Text] [Related]
10. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention. White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787 [TBL] [Abstract][Full Text] [Related]
11. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment. Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837 [TBL] [Abstract][Full Text] [Related]
12. A preliminary, controlled investigation of magnesium L-aspartate hydrochloride for illicit cocaine and opiate use in methadone-maintained patients. Margolin A; Kantak K; Copenhaver M; Avants SK J Addict Dis; 2003; 22(2):49-61. PubMed ID: 12703668 [TBL] [Abstract][Full Text] [Related]
13. Diminished illicit drug use as a consequence of long-term methadone maintenance. Gottheil E; Sterling RC; Weinstein SP J Addict Dis; 1993; 12(4):45-57. PubMed ID: 8292639 [TBL] [Abstract][Full Text] [Related]
14. Different components of opioid-substitution treatment predict outcomes of patients with and without a parent with substance-use problems. Trafton JA; Tracy SW; Oliva EM; Humphreys K J Stud Alcohol Drugs; 2007 Mar; 68(2):165-72. PubMed ID: 17286334 [TBL] [Abstract][Full Text] [Related]
15. Perceived stress related to methadone withdrawal. Carreras Alabau A; Carrobles Isabel JA; Almendros Rodríguez C Psicothema; 2016 Aug; 28(3):235-40. PubMed ID: 27448254 [TBL] [Abstract][Full Text] [Related]
16. Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia. Piralishvili G; Otiashvili D; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE J Subst Abuse Treat; 2015 Mar; 50():32-7. PubMed ID: 25456093 [TBL] [Abstract][Full Text] [Related]
17. Opiate-dependent patients receiving methadone. How physicians should manage therapy. Kahan M; Sutton N Can Fam Physician; 1996 Sep; 42():1769-78. PubMed ID: 8828879 [TBL] [Abstract][Full Text] [Related]
18. Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. Strain EC; Bigelow GE; Liebson IA; Stitzer ML JAMA; 1999 Mar; 281(11):1000-5. PubMed ID: 10086434 [TBL] [Abstract][Full Text] [Related]
19. Narcotics addiction treatment: behavioral methods concurrent with methadone maintenance. Bigelow G; Stitzer M; Lawrence C; Krasnegor N; D'Lugoff B; Hawthorne J Int J Addict; 1980 Apr; 15(3):427-37. PubMed ID: 7380601 [TBL] [Abstract][Full Text] [Related]
20. Predictors of retention in methadone programs: a signal detection analysis. Villafranca SW; McKellar JD; Trafton JA; Humphreys K Drug Alcohol Depend; 2006 Jul; 83(3):218-24. PubMed ID: 16384657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]